DEINOVE benefits from an experienced management team in research, development, finance and business development, a panel of high-level scientific experts and a Board of Directors highly qualified in the development of drugs and specialty compounds. This organization enables DEINOVE to develop an effective strategy that is relevant to the environment in which it operates.
Dr Charles WOLER, Chairman & CEO
MD, PhD in clinical pharmacology, MBA
Alexis Rideau, Deputy Chief Executive Officer
PhD in Molecular and Cellular Biology , European Magister in Genetics, MBA
Julien Coste, Director of Finance & Administration
Grenoble business school, Paris-Dauphine University
Georges Gaudriault, Scientific Director
PhD in molecular pharmacology
Marie Bézenger, Director of Operations
Engineer in Food sciences, PhD in Biochemistry, Cell & Molecular Biology
Sébastien Enault, Head of Business Développement
Engineer in Pharmacology & Biotechnologies
Johane Rinaldi, Head of HR
University of Lyon 2, University of Bordeaux 3
Coralie Martin, Head of Marketing, Communications and Investor Relations
Engineer in Biochemistry, Master in Business